Tag: PSA

UPDATE: 11/21/2025 Originally published Mar. 11, 2024 The blog below announced news that before radical prostatectomy (RP), multiparametric MRI findings can predict if a prostate cancer (PCa) patient is at risk of recurrence after RP. Prior to MRI predictions, the CAPRA-S score had become the gold standard for predicting biochemical recurrence risk—but only after the surgery was done. Thus, keep reading

Some men avoid doctor visits and underestimate their risk, but skipping annual check-ups can mean missing early prostate cancer. New advances like MRI can help avoid unnecessary biopsies and find cancer when it's most treatable. keep reading

Emerging research reveals that early PSA after radiation and androgen deprivation therapy can help predict prostate cancer outcomes. Meanwhile, a new genomic test is showing potential for identifying which patients face higher risk of long-term urinary side effects. keep reading

Did you know over 95% of prostate cancers share the same name—adenocarcinoma? This common cell type is usually slow-growing, but not always. Understanding how it develops, why PSA levels matter, and what early detection can reveal is key to knowing your best treatment options. keep reading

For decades, standard TRUS biopsies relied on 12+ random needles—missing aggressive cancers up to 46% of the time and increasing risks of infection. Today, real-time MRI-guided biopsies use just 2–4 precisely targeted needles, giving doctors clearer answers with fewer side effects. Discover why MRI-guided precision is changing prostate cancer diagnosis. keep reading

Each year, hundreds of thousands of men undergo prostate biopsies triggered by PSA results—many of them unnecessary. New research shows that combining PSA testing with MRI can more accurately identify significant cancers while sparing men from needless biopsies and the harms of overtreatment. keep reading

Today’s multiparametric MRI (mpMRI) has revolutionized the prostate cancer (PCa) world. Thanks to its high resolution, 3-dimensional imaging done by a powerful 3 Tesla (3T) magnet, experienced radiologists are able to identify areas that are suspicious for clinically significant PCa (csPCa). This helps avoid unnecessary biopsies, but if a biopsy is indicated, the area can keep reading

Okay, folks, this is BIG NEWS! A research study out of the esteemed Johns Hopkins University School of Medicine and two other academic centers may be the first of its kind to definitively connect healthy diet with reining in prostate cancer (PCa). Specifically, the study population was done with PCa patients currently on Active Surveillance keep reading

Once a popular prostate cancer treatment, brachytherapy has seen a sharp decline—and new research may reveal why. A study found that half of patients experienced cancer recurrence, challenging its long-term effectiveness. With evolving treatment options, it’s crucial to weigh the risks and benefits before choosing a path... keep reading

What does it mean when PSA levels rise after prostate cancer treatment—even years later? For many men, that first hint of a change can be both unsettling and significant. Catching biochemical recurrence early with scheduled PSA testing remains one of the most effective ways to stay ahead of potential cancer activity. keep reading